The Study of CM310 in Patients With Atopic Dermatitis

Clinical trial NCT04893707 · COMPLETED

Trial details

NCT number: NCT04893707
Sponsor: Keymed Biosciences Co.Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Moderate-to-severe Atopic Dermatitis

Start date: 2021-06-07
Primary completion: 2023-02-03
Enrollment: 127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.